litlas
Log inCreate account

Pierre Blier

Active 1983–2024

159
Papers
27,851
Citations
96
h-index
155
i10-index

Citations

Citations per year for Pierre Blier1984: 3 citations1985: 6 citations1986: 11 citations1987: 15 citations1988: 15 citations1989: 34 citations1990: 32 citations1991: 32 citations1992: 25 citations1993: 37 citations1994: 45 citations1995: 70 citations1996: 70 citations1997: 104 citations1998: 151 citations1999: 154 citations2000: 207 citations2001: 233 citations2002: 242 citations2003: 222 citations2004: 199 citations2005: 214 citations2006: 185 citations2007: 154 citations2008: 194 citations2009: 170 citations2010: 207 citations2011: 200 citations2012: 189 citations2013: 184 citations2014: 122 citations2015: 165 citations2016: 124 citations2017: 132 citations2018: 162 citations2019: 585 citations2020: 728 citations2021: 689 citations2022: 546 citations2023: 489 citations2024: 729 citations2025: 343 citations2026: 16 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,216 citing papers, 23.8% of this breakdownCanada: 911 citing papers, 9.8% of this breakdownChina: 670 citing papers, 7.2% of this breakdownUnited Kingdom: 656 citing papers, 7% of this breakdownItaly: 454 citing papers, 4.9% of this breakdownGermany: 438 citing papers, 4.7% of this breakdownFrance: 363 citing papers, 3.9% of this breakdownAustralia: 286 citing papers, 3.1% of this breakdownNetherlands: 270 citing papers, 2.9% of this breakdownSpain: 256 citing papers, 2.7% of this breakdownBrazil: 208 citing papers, 2.2% of this breakdownJapan: 207 citing papers, 2.2% of this breakdown
0%23.8%Other 25.6%

Institutions

Fields

  • Neuroscience38.7%
  • Medicine33.7%
  • Psychology10.6%
  • Biochemistry, Genetics and Molecular Biology9.7%
  • Agricultural and Biological Sciences2.3%
  • Environmental Science1.6%
  • Other3.4%

Topics

  • Treatment of Major Depression9.3%
  • Neurotransmitter Receptor Influence on Behavior8.8%
  • Tryptophan and brain disorders6.4%
  • Neuroscience and Neuropharmacology Research4.2%
  • Stress Responses and Cortisol3.6%
  • Receptor Mechanisms and Signaling3%
  • Other64.7%

Coauthors

All papers

Open in search
  1. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder

    Authors: Sidney H. Kennedy, Raymond W. Lam, Roger S. McIntyre, Smadar Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony Levitt, Glenda MacQueen, Shane McInerney, Diane McIntosh, Roumen Milev, Daniel J. Müller, Sagar V. Parikh, Norma L. Pearson, Arun Ravindran, Rudolf Uher, the CANMAT Depression Work Group - The Canadian Journal of Psychiatry 2016 cited by 1,123

  2. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

    Authors: Ella Daly, Madhukar H. Trivedi, Adam Janik, Honglan Li, Yun Zhang, Xiang Li, Rosanne Lane, Pilar Lim, A. Duca, David Hough, Michael E. Thase, John Zajecka, Andrew Winokur, Ilona Divacka, Andrea Fagiolini, Wiesław Jerzy Cubała, István Bitter, Pierre Blier, Richard C. Shelton, Patricio Molero, Husseini K. Manji, Wayne C. Drevets, Jaskaran Singh - JAMA Psychiatry 2019 cited by 759

  3. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

    Authors: Maggie Fedgchin, Madhukar H. Trivedi, Ella Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael R. Liebowitz, Arun Ravindran, Raphaël Gaillard, Hans van den Ameele, Sheldon Preskorn, Husseini K. Manji, David Hough, Wayne C. Drevets, Jaskaran Singh - The International Journal of Neuropsychopharmacology 2019 cited by 590

  4. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial

    Authors: Jennifer L. Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A. Batten, Pierre Blier - American Journal of Psychiatry 2019 cited by 411

  5. Monoamine neurocircuitry in depression and strategies for new treatments

    Authors: M. Hamon, Pierre Blier - Progress in Neuro-Psychopharmacology and Biological Psychiatry 2013 cited by 630

  6. A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

    Authors: Luca Sforzini, Courtney Worrell, Melisa Kose, Ian Anderson, Bruno Aouizerate, Volker Arolt, Michael Bauer, Bernhard T. Baune, Pierre Blier, Anthony J. Cleare, Philip J. Cowen, Timothy G. Dinan, Andrea Fagiolini, I. Nicol Ferrier, Ulrich Hegerl, Andrew D. Krystal, Marion Leboyer, R. Hamish McAllister‐Williams, Roger S. McIntyre, Andreas Meyer‐Lindenberg, Andrew H. Miller, Charles B. Nemeroff, Claus Normann, David Nutt, Stefano Pallanti, Luca Pani, Brenda W.J.H. Penninx, Alan F. Schatzberg, Richard C. Shelton, Lakshmi N. Yatham, Allan H. Young, Roland Zahn, Georgios Aislaitner, Florence Butlen‐Ducuing, Christine Fletcher, Marion Haberkamp, Thomas Laughren, Fanni-Laura Mäntylä, Koen Schruers, Andrew Thomson, Gara Arteaga-Henríquez, Francesco Benedetti, Lucinda Cash‐Gibson, Woo Ri Chae, Heidi De Smedt, Stefan M. Gold, Witte J.G. Hoogendijk, Valeria Jordán Mondragón, Eduard Maron, Jadwiga Martynowicz, Elisa Melloni, Christian Otte, Gabriela Pérez-Fuentes, Sara Poletti, Mark E. Schmidt, Edwin van de Ketterij, Katherine Woo, Yanina Flossbach, Josep Antoni Ramos‐Quiroga, Adam Savitz, Carmine M. Pariante - Molecular Psychiatry 2021 cited by 201

  7. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

    Authors: Martin A. Katzman, Pierre Bleau, Pierre Blier, Pratap Chokka, Kevin Kjernisted, Michael Van Ameringen - BMC Psychiatry 2014 cited by 1,091

  8. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

    Authors: Raymond W. Lam, Sidney H. Kennedy, G. Camelia Adams, Anees Bahji, Serge Beaulieu, Venkat Bhat, Pierre Blier, Daniel M. Blumberger, Elisa Brietzke, Trisha Chakrabarty, André Do, Benício N. Frey, Peter Giacobbe, David Gratzer, Sophie Grigoriadis, Jeffrey Habert, Muhammad Ishrat Husain, Zahinoor Ismail, Alexander McGirr, Roger S. McIntyre, Erin E. Michalak, Daniel J. Müller, Sagar V. Parikh, Lena C. Quilty, Arun Ravindran, Nisha Ravindran, Johanne Renaud, Joshua D. Rosenblat, Zainab Samaan, Gayatri Saraf, Kathryn Schade, Ayal Schaffer, Mark Sinyor, Cláudio N. Soares, Jennifer Swainson, Valerie H. Taylor, Smadar Valérie Tourjman, Rudolf Uher, Michael Van Ameringen, Gustavo Vázquez, Simone N. Vigod, Daphne Voineskos, Lakshmi N. Yatham, Roumen Milev - The Canadian Journal of Psychiatry 2024 cited by 303

  9. The identification, assessment and management of difficult-to-treat depression: An international consensus statement

    Authors: R. Hamish McAllister‐Williams, Celso Arango, Pierre Blier, Koen Demyttenaere, Peter Falkai, Philip Gorwood, Malcolm Hopwood, Afzal Javed, Siegfried Kasper, Gin S. Malhi, Jair C. Soares, Eduard Vieta, Allan H. Young, Ανδρέας Παπαδόπουλος, A. John Rush - Journal of Affective Disorders 2020 cited by 272

  10. International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators

    Authors: Rebecca B. Price, Nicholas Kissel, Andrew Baumeister, Rebecca Rohac, Mary L. Woody, Elizabeth D. Ballard, Carlos A. Zarate, J.F.W. Deakin, Chadi G. Abdallah, Adriana Feder, Dennis S. Charney, Michael F. Grunebaum, J. John Mann, Sanjay J. Mathew, Bronagh Gallagher, Declan M. McLoughlin, James W. Murrough, Suresh Muthukumaraswamy, Rebecca McMillan, Rachael L. Sumner, George I. Papakostas, Maurizio Fava, Rebecca S. Hock, Jennifer L. Phillips, Pierre Blier, Paulo Shiroma, P. Šóš, Tung‐Ping Su, Mu‐Hong Chen, Mikael Tiger, Johan Lundberg, Samuel T. Wilkinson, Meredith L. Wallace - Molecular Psychiatry 2022 cited by 79

  11. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L’humeur Et De L’anxiété (Canmat) Concernant L’utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur

    Authors: Jennifer Swainson, Alexander McGirr, Pierre Blier, Elisa Brietzke, Stéphane Richard‐Devantoy, Nisha Ravindran, Jean Blier, Serge Beaulieu, Benício N. Frey, Sidney H. Kennedy, Roger S. McIntyre, Roumen Milev, Sagar V. Parikh, Ayal Schaffer, Valerie H. Taylor, Valérie Tourjman, Michael Van Ameringen, Lakshmi N. Yatham, Arun Ravindran, Raymond W. Lam - The Canadian Journal of Psychiatry 2020 cited by 108

  12. Alpha power, alpha asymmetry and anterior cingulate cortex activity in depressed males and females

    Authors: Natalia Jaworska, Pierre Blier, Wendy Fusee, Verner Knott - Journal of Psychiatric Research 2012 cited by 247

  13. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems

    Authors: Stella Manta, Mostafa El Mansari, Guy Debonnel, Pierre Blier - The International Journal of Neuropsychopharmacology 2012 cited by 193

  14. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression

    Authors: Vincent Van den Eynde, Wegdan R. Abdelmoemin, Magid M. Abraham, Jay D. Amsterdam, Ian Anderson, Chittaranjan Andrade, Glen B. Baker, Aartjan T.F. Beekman, Michael Berk, Tom K. Birkenhäger, Barry Blackwell, Pierre Blier, Marc B.J. Blom, Alexander J. Bodkin, C Cattaneo, Bezalel Dantz, Jonathan Davidson, Boadie W. Dunlop, Ryan F. Estévez, Shalom S. Feinberg, J. P. M. Finberg, Laura J. Fochtmann, David Gotlib, Andrew Holt, Thomas R. Insel, Jens Larsen, Rajnish Mago, David B Menkes, Jonathan M. Meyer, David Nutt, Gordon Parker, Mark D. Rego, Elliott Richelson, Henricus G. Ruhé, Jerónimo Sáiz-Ruiz, Stephen M. Stahl, Thomas G. Steele, Michael E. Thase, S. Ulrich, Anton J.L.M. van Balkom, Eduard Vieta, Ian M. Whyte, Allan H. Young, Peter Kenneth Gillman - CNS Spectrums 2022 cited by 70

  15. Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.

    Authors: Stella Manta, Jianming Dong, Guy Debonnel, Pierre Blier - 2009 cited by 194

  16. Leveraging Machine Learning Approaches for Predicting Antidepressant Treatment Response Using Electroencephalography (EEG) and Clinical Data

    Authors: Natalia Jaworska, Sara de la Salle, Mohamed Hamza Ibrahim, Pierre Blier, Verner Knott - Frontiers in Psychiatry 2019 cited by 99

  17. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines.

    Authors: Konstantinos Ν. Fountoulakis, Heinz Grunze, Eduard Vieta, Allan H. Young, Lakshmi N. Yatham, Pierre Blier, Siegfried Kasper, Hans Jurgen Moeller - The International Journal of Neuropsychopharmacology 2016 cited by 251

  18. MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes

    Authors: Juan Pablo López, Laura M. Fiori, Cristiana Cruceanu, Rixing Lin, Benoît Labonté, Hannah M. Cates, Elizabeth A. Heller, Vincent Vialou, Stacy M. Ku, Christophe Gerald, Ming-Hu Han, Jane A. Foster, Benício N. Frey, Claudio N. Soares, Daniel J. Müller, Faranak Farzan, Francesco Leri, Glenda MacQueen, Harriet Feilotter, Kathrin Tyryshkin, Kenneth Evans, Peter Giacobbe, Pierre Blier, Raymond W. Lam, Roumen Milev, Sagar V. Parikh, Susan Rotzinger, Stephen C. Strother, Cathryn M. Lewis, Katherine J. Aitchison, Gayle Wittenberg, Naguib Mechawar, Eric J. Nestler, Rudolf Uher, Sidney H. Kennedy, Gustavo Turecki - Nature Communications 2017 cited by 206

  19. Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression

    Authors: Jennifer L. Phillips, Sandhaya Norris, Jeanne Talbot, Taylor Hatchard, Abigail Ortiz, Meagan Birmingham, Olabisi Owoeye, Lisa A. Batten, Pierre Blier - Neuropsychopharmacology 2019 cited by 133

  20. Differences between males and females in rates of serotonin synthesis in human brain

    Authors: Sadahiko Nishizawa, Chawki Benkelfat, Simon N. Young, Marco Leyton, Shadreck Mzengeza, Claude de Montigny, Pierre Blier, Mirko Dikšić - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 918

  21. Serotonin and beyond: therapeutics for major depression

    Authors: Pierre Blier, Mostafa El Mansari - Philosophical Transactions of the Royal Society B Biological Sciences 2013 cited by 254

  22. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

    Authors: Joseph Zohar, Stephen M. Stahl, Hans‐Jürgen Möller, Pierre Blier, David J. Kupfer, Shigeto Yamawaki, Hiroyuki Uchida, Michael Spedding, Guy M. Goodwin, David Nutt - European Neuropsychopharmacology 2015 cited by 182

  23. Data mining EEG signals in depression for their diagnostic value

    Authors: Mahdi Mohammadi, Fadwa Al-Azab, Bijan Raahemi, Gregory Richards, Natalia Jaworska, Dylan Smith, Sara de la Salle, Pierre Blier, Verner Knott - BMC Medical Informatics and Decision Making, BMC Medical Informatics Decis. Mak. 2015 cited by 111

  24. The noradrenergic paradox: implications in the management of depression and anxiety

    Authors: Alonso Montoya, Robert Bruins, Martin A. Katzman, Pierre Blier - Neuropsychiatric Disease and Treatment 2016 cited by 87